• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海洛因依赖者中海洛因使用、缓解及精神健康的模式与预测因素:澳大利亚治疗结果研究(ATOS)18 - 20年随访的关键发现

Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the 18-20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS).

作者信息

Marel Christina, Wilson Jack, Darke Shane, Ross Joanne, Slade Tim, Haber Paul S, Haasnoot Katherine, Visontay Rachel, Keaveny Madeleine, Tremonti Chris, Mills Katherine L, Teesson Maree

机构信息

University of Sydney Matilda Centre for Research in Mental Health and Substance Use, Sydney, NSW Australia.

National Drug and Alcohol Research Centre, UNSW Australia, Kensington, NSW Australia.

出版信息

Int J Ment Health Addict. 2023 Jan 18:1-18. doi: 10.1007/s11469-022-01006-6.

DOI:10.1007/s11469-022-01006-6
PMID:36688114
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9847452/
Abstract

UNLABELLED

This study aimed to investigate the long-term patterns and predictors of heroin use, dependence, and psychiatric health over 18-20 years among a cohort of Australians with heroin dependence, using a prospective longitudinal cohort study conducted in Sydney, Australia. The original cohort consisted of 615 participants, who were followed up at 3 months and 1, 2, 3, 11, and 18-20 years post-baseline; 401 (65.2%) were re-interviewed at 18-20 years. The Australian Treatment Outcome Study structured interview with established psychometric properties was administered to participants at each follow-up, addressing demographics, treatment and drug use history, overdose, crime, and physical and mental health. Overall, 96.7% completed at least one follow-up interview. At 18-20 years, 109 participants (17.7%) were deceased. Past-month heroin use decreased significantly over the study period (from 98.7 to 24.4%), with one in four using heroin at 18-20 years. Just under half were receiving treatment. Reductions in heroin use were accompanied by reductions in heroin dependence, other substance use, needle sharing, injection-related health, overdose, crime, and improvements in general physical and mental health. Major depression and borderline personality disorder (BPD) were consistently associated with poorer outcome. At 18-20 years, there is strong evidence that clinically significant levels of improvement can be maintained over the long term. The mortality rate over 18-20 years was devastating, with over one in six participants deceased. More sustained and targeted efforts are needed in relation to major depression and BPD to ensure evidence-based treatments are delivered to people with heroin dependence.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s11469-022-01006-6.

摘要

未标注

本研究旨在通过在澳大利亚悉尼进行的一项前瞻性纵向队列研究,调查一组有海洛因依赖的澳大利亚人在18至20年期间海洛因使用、依赖及精神健康的长期模式和预测因素。原始队列由615名参与者组成,在基线后3个月以及1、2、3、11和18至20年进行随访;401名(65.2%)参与者在18至20年时接受了再次访谈。在每次随访时,对参与者进行具有既定心理测量特性的澳大利亚治疗结果研究结构化访谈,内容涉及人口统计学、治疗和药物使用史、过量用药、犯罪以及身心健康。总体而言,96.7%的参与者完成了至少一次随访访谈。在18至20年时,109名参与者(17.7%)已死亡。在研究期间,过去一个月内使用海洛因的情况显著下降(从98.7%降至24.4%),四分之一的人在18至20年时使用海洛因。略少于一半的人正在接受治疗。海洛因使用的减少伴随着海洛因依赖、其他物质使用、共用针头、注射相关健康问题、过量用药、犯罪的减少,以及总体身心健康的改善。重度抑郁症和边缘型人格障碍(BPD)始终与较差的结果相关。在18至20年时,有强有力的证据表明,临床上显著的改善水平可以长期维持。18至20年期间的死亡率令人震惊,超过六分之一的参与者死亡。对于重度抑郁症和BPD,需要做出更持续和有针对性的努力,以确保为有海洛因依赖的人提供循证治疗。

补充信息

在线版本包含可在10.1007/s11469-022-01006-6获取的补充材料。

相似文献

1
Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the 18-20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS).海洛因依赖者中海洛因使用、缓解及精神健康的模式与预测因素:澳大利亚治疗结果研究(ATOS)18 - 20年随访的关键发现
Int J Ment Health Addict. 2023 Jan 18:1-18. doi: 10.1007/s11469-022-01006-6.
2
Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-year findings from the Australian Treatment Outcome Study.海洛因依赖的长期死亡率、缓解情况、犯罪行为及精神疾病共病:澳大利亚治疗结果研究的11年随访结果
Addiction. 2015 Jun;110(6):986-93. doi: 10.1111/add.12860. Epub 2015 Mar 2.
3
Australian treatment outcome study: protocol for the 18-20-year follow-up of a prospective longitudinal cohort examining the natural history of heroin dependence and associated mortality, psychiatric and physical health, and health service use.澳大利亚治疗结果研究:对前瞻性纵向队列进行 18-20 年随访的方案,该队列旨在研究海洛因依赖的自然史以及相关死亡率、精神和身体健康状况,以及卫生服务利用情况。
BMJ Open. 2020 Jul 12;10(7):e039226. doi: 10.1136/bmjopen-2020-039226.
4
The long-term impact of post traumatic stress disorder on recovery from heroin dependence.创伤后应激障碍对海洛因依赖康复的长期影响。
J Subst Abuse Treat. 2018 Jun;89:60-66. doi: 10.1016/j.jsat.2018.04.001. Epub 2018 Apr 4.
5
The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).治疗对海洛因依赖3年预后的影响:澳大利亚治疗结果研究(ATOS)的发现。
Addiction. 2008 Jan;103(1):80-8. doi: 10.1111/j.1360-0443.2007.02029.x. Epub 2007 Nov 8.
6
Borderline personality disorder and persistently elevated levels of risk in 36-month outcomes for the treatment of heroin dependence.边缘型人格障碍与海洛因依赖治疗36个月结果中持续升高的风险水平。
Addiction. 2007 Jul;102(7):1140-6. doi: 10.1111/j.1360-0443.2007.01876.x.
7
The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence.边缘型人格障碍对海洛因依赖治疗12个月结局的影响。
Addiction. 2005 Aug;100(8):1121-30. doi: 10.1111/j.1360-0443.2005.01123.x.
8
Patterns and correlates of non-fatal heroin overdose at 11-year follow-up: findings from the Australian Treatment Outcome Study.11年随访中非致命性海洛因过量使用的模式及相关因素:澳大利亚治疗结果研究的发现
Drug Alcohol Depend. 2014 Nov 1;144:148-52. doi: 10.1016/j.drugalcdep.2014.09.001. Epub 2014 Sep 16.
9
Static and dynamic predictors of criminal involvement among people with heroin dependence: findings from a 3-year longitudinal study.静态和动态因素预测海洛因依赖者的犯罪参与:一项为期 3 年的纵向研究结果。
Drug Alcohol Depend. 2013 Dec 1;133(2):600-6. doi: 10.1016/j.drugalcdep.2013.08.003. Epub 2013 Aug 13.
10
Young people with heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).患有海洛因依赖的年轻人:澳大利亚治疗结果研究(ATOS)的发现。
J Subst Abuse Treat. 2004 Jul;27(1):67-73. doi: 10.1016/j.jsat.2004.05.001.

引用本文的文献

1
Characteristics of attrition within the SuperMIX cohort of people who inject drugs: a multiple event discrete-time survival analysis.在注射吸毒者的 SuperMIX 队列中,损耗的特征:多事件离散时间生存分析。
BMC Med Res Methodol. 2024 Oct 30;24(1):257. doi: 10.1186/s12874-024-02377-1.
2
Differences in heroin overdose deaths in Australia by age, 2020-2022: Disease and estimated survival times.2020 - 2022年澳大利亚按年龄划分的海洛因过量死亡差异:疾病与估计存活时间
Drug Alcohol Depend Rep. 2024 Jan 20;10:100217. doi: 10.1016/j.dadr.2024.100217. eCollection 2024 Mar.

本文引用的文献

1
Peer Support and Overdose Prevention Responses: A Systematic 'State-of-the-Art' Review.同伴支持和过量预防反应:系统的“最新技术”综述。
Int J Environ Res Public Health. 2021 Nov 17;18(22):12073. doi: 10.3390/ijerph182212073.
2
The Effect of Overdose Education and Naloxone Distribution: An Umbrella Review of Systematic Reviews.过量用药教育和纳洛酮分销的效果:系统评价的伞式综述。
Am J Public Health. 2021 Aug;111(8):e1-e12. doi: 10.2105/AJPH.2021.306306. Epub 2021 Jul 2.
3
Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018.
欧洲是否正在面临类似美国的阿片类药物危机?对 2010 年至 2018 年 19 个欧洲国家阿片类药物使用情况及相关不良反应的分析。
Eur Psychiatry. 2021 Jun 21;64(1):e47. doi: 10.1192/j.eurpsy.2021.2219.
4
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis.阿片类激动剂治疗与阿片类药物依赖患者全因死亡率及特定死因的相关性:系统评价和荟萃分析。
JAMA Psychiatry. 2021 Sep 1;78(9):979-993. doi: 10.1001/jamapsychiatry.2021.0976.
5
Explaining the Differences in Opioid Overdose Deaths between Scotland and England/Wales: Implications for European Opioid Policies.解释苏格兰和英格兰/威尔士之间阿片类药物过量死亡的差异:对欧洲阿片类药物政策的影响。
Eur Addict Res. 2021;27(6):399-412. doi: 10.1159/000516165. Epub 2021 May 7.
6
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
7
Australian treatment outcome study: protocol for the 18-20-year follow-up of a prospective longitudinal cohort examining the natural history of heroin dependence and associated mortality, psychiatric and physical health, and health service use.澳大利亚治疗结果研究:对前瞻性纵向队列进行 18-20 年随访的方案,该队列旨在研究海洛因依赖的自然史以及相关死亡率、精神和身体健康状况,以及卫生服务利用情况。
BMJ Open. 2020 Jul 12;10(7):e039226. doi: 10.1136/bmjopen-2020-039226.
8
Global patterns of opioid use and dependence: harms to populations, interventions, and future action.全球阿片类药物使用和依赖模式:对人群的危害、干预措施和未来行动。
Lancet. 2019 Oct 26;394(10208):1560-1579. doi: 10.1016/S0140-6736(19)32229-9. Epub 2019 Oct 23.
9
Medication Treatment of Opioid Use Disorder.阿片类药物使用障碍的药物治疗。
Biol Psychiatry. 2020 Jan 1;87(1):82-88. doi: 10.1016/j.biopsych.2019.06.020. Epub 2019 Jul 2.
10
Trends in age-related disease burden and healthcare utilization.与年龄相关的疾病负担和医疗保健利用趋势。
Aging Cell. 2019 Feb;18(1):e12861. doi: 10.1111/acel.12861. Epub 2018 Nov 29.